Topics

Companies Related to "2019 Interstitial Lung Diseases Clinical Trials Guide Companies" [Most Relevant Company Matches] - Page: 20 RSS

20:07 EST 28th February 2020 | BioPortfolio

Here are the most relevant search results for "2019 Interstitial Lung Diseases Clinical Trials Guide Companies" found in our extensive corporate database of over 50,000 company records.

Showing "2019 Interstitial Lung Diseases Clinical Trials Guide Companies" Companies 476–500 of 8,600+

Probably Relevant

Viroclinics Biosciences B.V.

Viroclinics Biosciences BV (Viroclinics) is a virology contract research organization, serving the biopharmaceutical community as a pre-clinical and clinical reference laboratory for supporting the development of new chemical entities, vaccines and antiviral compounds targeting viral infectious diseases. Viroclinics was founded in 2001 as a spin-off from the virology department at the Erasmus...


Cobalis

Although Cobalis’ current research is focused on studying the effects of cyanocobalamin (the active ingredient in PreHistin™) on the reduction of symptoms associated with seasonal and perennial allergic rhinitis, we plan to sponsor clinical trials into other immunoglobulin-E (IgE)-mediated allergic diseases to expand our product line. These supplemental indications include: :: Pediatric do...

Ario Pharma Ltd

ario pharma ltd focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1 inhibitor, in two Phase 2 clinical trials that will read out in 2014. The company is managed by a highly experienced development team and supported by world-renowned KOLs in respiratory disease. Co...


Odyssey Thera, Inc.

Odyssey Thera Inc. is a drug discovery company that has developed a global cellular pharmacology strategy for the identification of safe and effective medicines for a wide spectrum of human diseases. The company’s mission is to transform the predictability and speed of drug discovery through an understanding of the entire scope of drug action, prior to clinical trials. The company’s initial pr...

Align Clinical CRO

“Leading experts are coming together in Align Clinical CRO to streamline how data is shared between CROs and sponsors during trials,” said Thomas O’Leary, chief information officer at ICON plc. “We look forward to contributing to the group and creating standards that drive greater speed and productivity across the industry.”

Tri-Institutional Therapeutics Discovery Institute, Inc

The independent, nonprofit institute, which will have its own scientific advisory board and board of directors, will build a strong bridge between early-stage research discoveries and the development of new diagnostic and therapeutic agents for myriad health challenges, reflecting the diverse interests of the member institutions’ faculty. Projects that will be tackled could range from addr...

Vicus Therapeutics, LLC

Vicus Therapeutics is a biopharmaceutical company dedicated to bringing breakthrough therapies to patients with cancer. Vicus' lead investigational therapy, VT-122, is a combination of etodolac and propranolol. VT-122 showed positive results in a Phase 2 clinical trial of lung cancer patients and is currently being evaluated in a Phase 2 clinical trial of liver cancer patients receiving Nexavar ...

Prologue Research, Inc.

Prologue Research, Inc., is a leading oncology contract research organization ("CRO") founded in 1998. The Company offers a full range of clinical research services for Phase I-IV clinical trials in oncology and oncology-related studies. Prologue provides its clients with world-class industry experience and computerized expert systems uniquely designed for complicated oncology trials that enable b...

HealthCare Pharmaceuticals, Inc.

HealthCare Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel, targeted therapies for the treatment of patients with cancer. DKN-01, our clinical-stage monoclonal antibody, is currently being tested in Phase 1b and Phase 2 clinical trials for patients with DKK1+ esophageal cancer and multiple mye...

Astralis Ltd.

In January 2004, Astralis Ltd received its first patent from the United States Patent Office. This achievement has resulted from the quality and focus of our therapeutic research and development. Astralis intends to continue its growth through discovery and development of its own innovative products. "Strategic partnerships" will allow the company to develop and commercialize its products more eff...

deCODE genetics

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the bas...

Karo Bio AB

Karo Bio is an innovative drug discovery and development company specializing in nuclear receptors for the development of novel pharmaceuticals. The company has a strong project portfolio primarily targeting metabolic diseases such as diabetes, obesity, atherosclerosis and dyslipidemia. Karo Bio has expanded from being a drug discovery company by adding in-house preclinical development resources a...

Intercern

Intercern is a pan-European clinical trials network supported by teams of dedicated clinical research professionals. We offer consultancy, design, implementation and running of phase I-IV clinical studies. Intercern can demonstrate radical improvements over the traditional expectations of study timelines and patient recruitment targets.Intercern represents a network of over 200 premier clinical tr...

Chooper's Guide

NovImmune SA

NovImmune SA (‘NovImmune’) is a drug discovery and development company with a focus on therapeutic mAbs for inflammatory diseases and immune-related disorders. NovImmune has generated, to date, seven proprietary mAbs. The pipeline is a balance of preclinical and clinical compounds, with a mix of both clinically validated as well as novel targets....

LeapFrog Investments

LeapFrog invests in exceptional businesses in Africa and Asia, partnering with their leaders to achieve leaps of growth, profitability and impact. LeapFrog companies now reach 168 million people across 35 countries with healthcare or financial services. Over 136 million of those individuals are emerging consumers, often accessing quality insurance, savings...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...

MAT & Asociados - Clinical Research Organisation

MAT & Asociados is a CRO with offices in Argentina and Uruguay, specialized in collaborating with pharmaceutical and biotechnological companies in product development activities. The company counts on highly-qualified technicians and professionals whose resources are devoted to fulfilling the specific requirements of different areas in the industry, strictly adhering to GCP and ICH norms.Since 199...

Keats Healthcare

Sourcing and distributes comparator drugs for the global clinical trials industry

InflaRx GmbH

InflaRx is a clinical-stage biopharmaceutical company focusing on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. The company is also developing addi...

Naviscan Inc.

Naviscan Inc., founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging, guide radiological and surgical procedures and advance new clinical therapies. The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the U.S. as well as utilized in clinical research studies, funded in par...

Kyruus Inc.

Kyruus is a health care Big Data company that provides solutions to health care organizations seeking to meet the unique challenges of today’s regulatory and economic environment. As providers adapt to critical operational, financial, and clinical challenges, Kyruus enables effective integration of disparate data sets in order to guide institutional d...

ClinStar, LLC

ClinStar is one of the most prominent clinical research organizations in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical research studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with ...

ClinStar LLC

ClinStar is one of the most prominent clinical research organizations in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical research studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with ...

PHARMBIODYN

PHARMBIODYN offers: Analytics, Metabolism, Drug-screening, Drug-efficacy in preclinical studies clinical trials (phase I-III) development and application of pharmaco-dynamic models concerning the early and late preclinical as well as the clinical phases.


More From BioPortfolio on "2019 Interstitial Lung Diseases Clinical Trials Guide Companies"

Quick Search

Corporate Database Quicklinks